saxodoc's profile picture.

Javier Morales

@saxodoc

Congratulations to NovoNordisk on the SELECT trial results with an astounding 20% reduction in major adverse cardiovascular events. This is just another example of how important the GLP1RA class actually is!!


Perspectives on Chronic Kidney Disease With Type 2 Diabetes and Risk Management: Practical Viewpoints and a Paradigm Shift Using a Pillar Approach | Clinical Diabetes | American Diabetes Association diabetesjournals.org/clinical/artic…


Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease: ... sciencedirect.com/science/articl…


Is Synergism the Secret to Success? Candid Conversations on Targeting GIP and GLP-1 to Individualize Treatment in Patients With T2DM and Obesity learn2.peerview.com/150207503_1_we…


Dorzagliatin as Add-On Therapy to Metformin in Patients With Type 2 Diabetes prac.co/l/2b5p64ml via @practiceupdate


Meta analysis suggests that human based long acting GLP1 receptor agonists may reduce risk of stroke!!!!


Diabetes increases cardiovascular risk with a three fold increase in major adverse cardiovascular events. Have you considered how to reduce this risk?


PeerView - Is Synergism the Secret to Success? Candid Conversations on Targeting GIP and GLP-1 to Individualize Treatment in Patients With T2DM and Obesity learn2.peerview.com/150207503_1/15…


Loading...

Something went wrong.


Something went wrong.